why from Las Vegas it's the cube covering informatica world 2018 bacio by inform Attica hey welcome back it runs the cubes exclusive coverage of informatica world 2018 we're here at the Venetian in Las Vegas live I'm John for your co-host with Peterborough's coasting and head of analyst said we keep on insulating all the cube our next guest is jammed the dalla who's the enterprise analytics architecture engineer sire pharmaceutical and some named director of the enterprise analytic solutions lead at sire as well great to have you guys thanks for joining us thank you so love getting the practitioner view of kind of the reality right of what's going on off see dramatic has their show you guys are a customer you're looking at some of their products take a minute first to talk about what you guys do first see Pharma got some stuff going on Davies involved privacy's involves you're in Europe in the u.s. GDP ours here think I'm gonna talk about what you guys do sure so char Pharmaceuticals is a global leader in rare diseases so there's about 350 million patients who are effective remedies is today and so art group with NIT enterprise analytics so we're focused on making sure we bring the right technologies and capabilities around bi and analytics to the organization so we look at products tools figure out how they fit into our our ecosystem of bi stack of tools and make that available to our RIT colleagues as well as our business colleagues so rare disease can you just explain kind of categorically what that is cuz I'm assuming this fits rare is not a lot of data on it or there's data you got to figure out what is that how do you guys categorize that so rare disease you know majority the rare disease affected by affected children so that's a kind of a critical aspect of what we do you know rare disease could be in immunology it could be in oncology GI I mean there's very disease typically you know people who are affected affected probably less than a thousand or 2,000 I think one of our drugs the population is around 5,000 people and these are chronic diseases typically their chronic diseases so they're they're they're diseases that affect the quality of life of an individual so what you guys are doing is identifying what is it about the genealogy etc the genome associated with the disease but then providing treatments that will allow especially kids an opportunity to have live a better life over extensive time yeah and what do you guys do there in terms the data side can you explain what your roles are yeah so like I said we're you're in the enterprise analytics so we're focused on bringing technologies and capabilities around bi and analytics spaces so how do we bring data in and ingest it how do we curate the data how do we do if data visualizations how do we do data discovery advanced analytics so all of those kind of capabilities and we're responsible for so what's your architecture today you have some on premises their cloud involved you just kind of lay out kind of the environment as much as you can share I know maybe some confidential information but for the most part what's the current landscape internally for you guys what are you dealing with the data sure so we fill out a new a new next generation analytics we called it our marketplace or the analytics marketplace we're leveraging both on Prem as well as cloud technologies so we're leveraging Microsoft Azure hdinsight for Hadoop the Big Data technologies as well as informatica for data ingestion and bringing data and transform or transforming yet but there are many tools involved in that one so it's like the whole ecosystem we call does marketplace which is backbone for shared enterprise analytics strategy and future you guys put a policy around what tools people can bring to work so to speak and we're seeing a proliferation of tools there's a tool vendor everywhere we look around the big data it's right I got a tool for this I got a tool for wrangling I've seen everything how do you guys deal with that onslaught of tools coming in do you guys look at it more from a platform respective how are you guys handling that right so look at a platform perspective and we try to bring tools in and make that a standard within the organization we look at you know the security is it enterprise grade technology and yeah it's a challenge I mean they're basically certified you kick the tires give it a pace test through its paces and then we have our own operations team so we can support that that tool set the platform itself so and what are your customers do with the data they doing self service or they data scientists are they like just business analysts what's the profile of the users of your customers of your we have all set of users they have like a technical folks which they want to use the data like traditional ETL reality so there are folks from the business they want to do like self-serve and unless they want to do analysis on the data so we have all the capabilities in our marketplace so some tools enable those guys to get the data for the selves or like the tools we have and dalibor does their own stuff like the eld talk a little bit about the one of the key challenges associated with pharmaceuticals especially in the types of rare disease chronic young people types of things that you guys are mainly focused on a big challenge has always been that people when they start taking a drug that can significantly improve their lives they start to feel better and when they start to feel better they stop taking it so how are you using big data to or using analytics to identify people help describe potential treatments for them help keep them on the regimen how do you do are you first of all are you doing those things and as you do it how are you ensuring that you are compliant with basic ethical and privacy laws and what types of tools are you using to do that it's a big question yeah yeah so we are doing some of that you know we have looked at things around persistence and adherence and understanding kind of you know what what combination of drugs may work best for certain individuals or groups of people yeah and definitely you know some compliance is a big factor in that so when I'm working close with a compliance group understanding how we're allowed to use that data in between which parts of the organization do you anticipate that you'll have a direct relationship as some of these customers or is there an optimist in other words does analytics provide you an opportunity to start to alter the way that you engage the core users of your products and services like I believe so you know I think one thing that we're looking at which strategic standpoint is um how do we diagnose people sooner a lot of these chronic diseases you know they go through 2-3 years of undiagnosed so they'll jump around from you know doctor a doctor if I understand what you know what the issue is so I think one thing we're looking at is how do we use data and AI to to more quickly be able to diagnose patients has a 360 view helped you guys of data you guys have a 360 view how do you cuz we'll look at that in terms of a channel selling a product and serving because we have a different perspective what's the 360 view benefit that you guys are getting yeah so we have a kind of a customer care model which is kind of a 360 for our customer so understanding you know around just drug manufacturing to making sure they have the right you know they have the right supply to understand is it working for the patient's so we've always been talking about the role a big day you mentioned had to do that Hadoop supposed to be this whole industry now it's a feature of data right so there's a variety of you know infrastructure as a service platform as a service some say I pass and Big Data how are you guys looking at that as as as builders of IT next-generation IT the role of I pass and Big Data we see it as a role in a blur you know I think what cloud brings us in the past type solutions is agility you know we as the market is so evolving so quickly and there's new versions of new software coming out so quickly that you wanna be able to embrace that and leverage that give it benefit of like give it some sort of a comparison old way versus a cloud like is there been some immediate benefits that just pop out yeah that a lot more benefits with doing the world way and the cloud way because with the cloud that brings a lot more scalability in in all India's to get like 10 servers you need to work with the infrastructure team I get it like it takes three months or two months again it with the cloud based one you've worked out you can scale up or scale down so that's one thing because it's so you're talking about Big Data yeah you're getting the volume of data you're getting you need to scale up your storage or your any compute you either JMS and compute bring data to the table and then you gotta have the custom tooling for the visualization yeah how that kind of together right you talk about them from your perspective the balance that you have to have guys have to deal with every day like you got to deal with the current situation NIT you got cloud you got an electrical customers personas of people using the product but you got to stay in the cutting edge it's like what's next cuz we going down the cloud road you're looking at containers kubernetes service meshes you need a lot more stuff coming down the pike if you will coming down the road for you guys how are you guys looking at that and how are you managing it you have some greenfield projects do you do a little you know Rd you integrated in how are you dealing with this new cloud native set of technologies yeah definitely a balancing act you know I think we do a lot of pocs and we actually work with our business and IT counterparts to see hey if there's a new use case that is coming down you know how do we solve that use case with some of the newer technologies and we try a POC may bring in a product to just see if it works and then see how do we then do we then take that to the enterprise so I got one final question for you guys and maybe you do as well John but but in life and death businesses like pharmaceuticals is a life and death business the quality of the data is really really important getting it wrong has major implications the fidelity of the system is really crucial you say using informatica for for example ingest and other types of services how has that choice made the business feel more certain about the quality of their data that you're using in your analytic systems into standardization so you know if between MDM round mastering our data - ingesting data transforming our data just having that data lineage having that standard around how that data gets transformed is that fundamentally a feature of the services that you're providing is you not only were you you know the ability to do visualization on data but actually providing your scientists and your businesspeople and your legal staff explicit knowledge about where this data came from and how trustworthy it is and whether they should be making these kind of free complex very real hardcore human level decisions on is that is that all helping yes because it seems like it would be a really crucial determination of what tools you guys would use right it is yeah and absolutely I think also as we move more towards self-service and having these people having data scientists do their things on their own being able to have the tools that can do that kind of audit and data lineage is crucial great to have you guys on we had a wrap I want to ask one more question here you guys were an innovation award e informática congratulations any advice for your peers out there want to unleash the power data and be on the cutting edge and potentially be an honoree yeah I would say just definitely think outside the box seem to try new things try puce you know do POCs is there so much new technologies coming down so quickly that it's hard to keep up Jam cuz it's like a moving target you need to chase your movie target and based on B was it that gets you like what you want it to do you know siding yeah get out front don't keep your eye on the prize yeah focus on task at hand bring in the new technologies guys thanks so much for coming on great to hear the practitioners reality from the trenches certainly front lines you know life-or-death situations of quality of the data matter scaling is important cloud era of data I'm John for a Peterborough's more live coverage after the short break